// App-Quantinova.ai

: RISK FACTORS OF PREECLAMPSIA IN PREGNANT WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Researchers

Presenter

  • Tatiana Kirsanova

Principal Investigators

  • Olga Tsatsulina

  • Maria Vinogradova

  • Tatiana Fedorova

  • Elizaveta Rumiantseva

  • Nina Rozina

Medical Centers

  • Federal State Budget Institution “Research Center for Obstetrics, Gynecology and Perinatology” MoH, Russian Federation

  • Moscow State University, Moscow, Russia

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Obstetrics/Gynecology

  • Endocrine/metabolic Diseases (ME)

Disease

  • Lupus

  • Preeclampsia

  • Albuminuria

Biomarkers

  • Alanine transaminase

  • Aspartate aminotransferase

  • Creatinine

  • D-dimer

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

  • Fibrinogen (IV)

  • Aspirin

  • Albyl-E

Outcome

  • N/A


Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A